Table 1. Frequency of TERT promoter and CTNNB1 mutations in hepatocellular nodules.

		TERT C228T & C250T status		CTNNB1 status
	Total	Wild type	Mutant	Wild type	Mutant
	(n = 156)	(n = 107)	(n = 45)	(n = 127)	(n = 17)
Hepatic adenoma	9	9 (100%)	0	8 (88.9%)	1 (11.1%)
Regenerating nodule	4	4 (100%)	0	2 (100%)	0
Low grade dysplastic nodule (Large cell change)	10	10 (100%)	0	8 (100%)	0
High grade dysplastic nodule	7	7(100%)	0	6 (100%)	0
Hepatocellular carcinoma	123	74 (60.2%)	45 (36.6%)	100 (86.2%)	16 (13.8%)
Combined hepatocellular carcinoma and cholangiocarcinoma	3	3 (100%)	0	3 (100%)	0